These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32340775)

  • 1. Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agents.
    Lordan R; Tsoupras A; Zabetakis I
    Blood Rev; 2021 Jan; 45():100694. PubMed ID: 32340775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Platelet Aggregation in Atherosclerosis.
    Lordan R; Tsoupras A; Zabetakis I
    Methods Mol Biol; 2022; 2419():333-347. PubMed ID: 35237975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD.
    Müller KA; Chatterjee M; Rath D; Geisler T
    Thromb Haemost; 2015 Aug; 114(3):498-518. PubMed ID: 26224127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of platelets in inflammation and cancer: novel therapeutic strategies.
    Dovizio M; Alberti S; Guillem-Llobat P; Patrignani P
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):118-27. PubMed ID: 24118902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets in atherosclerosis.
    Lievens D; von Hundelshausen P
    Thromb Haemost; 2011 Nov; 106(5):827-38. PubMed ID: 22012554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of platelet and leucocyte function by a Chinese herbal formulation as compared with conventional antiplatelet agents.
    Zhao L; Gaudry L; Dunkley S; Brighton T; Guo ZX; Ye ZL; Luo RZ; Chesterman CN
    Platelets; 2008 Feb; 19(1):24-31. PubMed ID: 18231935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maresin 1 induces a novel pro-resolving phenotype in human platelets.
    Lannan KL; Spinelli SL; Blumberg N; Phipps RP
    J Thromb Haemost; 2017 Apr; 15(4):802-813. PubMed ID: 28079976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antiplatelet therapy on platelet extracellular vesicle release and procoagulant activity in health and in cardiovascular disease.
    Connor DE; Ly K; Aslam A; Boland J; Low J; Jarvis S; Muller DW; Joseph JE
    Platelets; 2016 Dec; 27(8):805-811. PubMed ID: 27310292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of platelets in athero-thrombotic events.
    Freynhofer MK; Bruno V; Wojta J; Huber K
    Curr Pharm Des; 2012; 18(33):5197-214. PubMed ID: 22724408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
    Rozalski M; Nocun M; Watala C
    Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen interaction with human platelets: effect of other coagulation factors, prostaglandins and platelet inhibitors.
    Al-Mondhiry H; Ballard JO; McGarvey V
    Thromb Res; 1983 Aug; 31(3):415-26. PubMed ID: 20217998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of low-grade inflammation on platelets in patients with stable coronary artery disease.
    Larsen SB; Grove EL; Würtz M; Neergaard-Petersen S; Hvas AM; Kristensen SD
    Thromb Haemost; 2015 Aug; 114(3):519-29. PubMed ID: 26062929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Efficacy and Safety of Antiplatelet Therapeutics in Rabbits.
    Kuszynski DS; Christian BD; Bernard MP; Lauver DA
    Curr Protoc; 2023 Mar; 3(3):e711. PubMed ID: 36921209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
    Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet properties of natural products.
    Vilahur G; Badimon L
    Vascul Pharmacol; 2013; 59(3-4):67-75. PubMed ID: 23994642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets as therapeutic targets to prevent atherosclerosis.
    Nording H; Baron L; Langer HF
    Atherosclerosis; 2020 Aug; 307():97-108. PubMed ID: 32653088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts and novel targets for antiplatelet therapy.
    Gawaz M; Geisler T; Borst O
    Nat Rev Cardiol; 2023 Sep; 20(9):583-599. PubMed ID: 37016032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelets and antiplatelet therapy in cardiovascular disease.
    Ueno M; Kodali M; Tello-Montoliu A; Angiolillo DJ
    J Atheroscler Thromb; 2011; 18(6):431-42. PubMed ID: 21427504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.
    Nagy B; Miszti-Blasius K; Kerenyi A; Clemetson KJ; Kappelmayer J
    Curr Med Chem; 2012; 19(4):518-31. PubMed ID: 22204330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.